Evaluation of abnormal uterine bleeding

Stephen C. Rubin, MD
Last Modified: June 16, 2002


Dear OncoLink "Ask The Experts,"
I am 45 and having mid cycle bleeding. This has been happening for about 6 months. My doctor observed during my physical exam that my uterus was enlarged. I had an ultrasound and was told that I have multiple fibroids. Recently, I have been having constant lower left abdominal pain and leg aches. Much like I am constantly ovulating. I am worried that I may have more than just fibroids. Should I ask my physician to do a D&C to rule out the possibility of Uterine Cancer?  


Stephen C. Rubin, MD, Professor and Chief of the Division of Gynecologic Oncology, University of Pennsylvania Health System, responds:

The evaluation of abnormal uterine bleeding depends on a number of considerations, including the patient's age, and potential risk factors for cancers, particularly of the uterine lining (endometrium) and cervix. In women over 40, or younger women who have risk factors for endometrial cancer such as obesity or irregular ovulation, an evaluation of the endometrium is appropriate. This can often be accomplished in the doctor's office with a simple biopsy. Alternatives may include D&C, and sonography to visualize the uterine lining and gynecologic organs. I suggest you discuss the possibility of a biopsy with your physician. There are many benign causes of uterine bleeding such as fibroids or polyps, but uterine cancer should be ruled out.


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Young Cancer Patients at High Risk for Heavy Menstrual Bleeding

Jul 29, 2014

Oncologist and gynecologist should collaborate to provide appropriate treatment

SGO: Bariatric Surgery Linked to Reduced Uterine Cancer Risk

Mar 25, 2014

Second study shows BRCA1 carriers have increased risk of high-risk uterine cancer

Robotic Surgery May Be Superior to Laparoscopic for Uterine CA

Nov 18, 2015

Robotic is more costly, but results in shorter length of stay and greater rate of lymph node dissection

From the National Cancer Institute